The Auragens Standard · Auracells™
Auracells™ aren’t something we purchase from a third party and simply administer. They are the product of an integrated process, from responsibly sourced tissue to the ongoing evaluation of patient outcomes.
Made by Auragens
Auracells™ come from Auragens, not a third party. We control the entire journey, from source to patient, so we can stand behind every step of it. Because in regenerative medicine, the product isn’t just what’s inside the vial.
Independently Verified
Part of our AABB accreditation, the Cellular Starting Material (CSM) designation is third-party recognition that Auragens is qualified to produce its own cellular product. Our laboratory is also FDA-registered.

Not a Commodity
Anyone can talk about cell count. We talk about cell quality, consistency and accountability.
“Auracells™ are not defined by cell count. They’re defined by everything that happens before they ever reach the patient.”
From Source to Patient
We take responsibility for the whole journey, so every Auracell™ is backed by the same people, laboratory and standards.
The Auragens Standard
Every Auracell™ carries the work of an entire system behind it. These are the six things that travel with every vial.
And the accountability connecting all of them.
That’s the Auragens Standard · That’s why we created Auracells™
Laboratory & Clinic, Together
What we learn clinically informs how we keep improving our process. Auracells™ represent everything we’ve learned from manufacturing, testing, administering and following cellular therapies over time.

Defined
Auragens’ standard for what a therapeutic cell should be.
For clinicians: Auracells™ are umbilical cord–derived mesenchymal stem/stromal cells (hUC-MSCs) from Wharton’s Jelly, characterized against ISCT minimal criteria.

Auracells™ FAQs
They’re Auracells™. That name represents our entire standard, from source to patient. We control the process, operate within an AABB-accredited cellular therapy framework, independently test the product, administer it through experienced physicians and track what happens afterward. We believe you can’t separate the quality of the cell from the quality of the process that produced it.
Yes. Auracells™ are umbilical cord–derived mesenchymal stem/stromal cells (hUC-MSCs) from Wharton’s Jelly. The name reflects the standard and process behind them, not just the cell type.
From donated umbilical cord tissue collected after healthy, full-term births, a process that is non-invasive for mother and newborn. Every donor undergoes comprehensive health and infectious-disease screening.
No. Auracells™ are produced by Auragens in our own laboratory. Our AABB Cellular Starting Material designation is third-party recognition that we are qualified to produce our own cellular product.
Cell count alone says little about a cell’s quality. We focus on what determines it: sourcing, manufacturing, testing, accreditation, administration and follow-up.
Mesenchymal stem cell therapy is investigational for most of the conditions we evaluate and is not approved by the U.S. Food and Drug Administration as a standard treatment for them. Our medical team presents the current evidence, including its limitations, to every patient.
Yes. Clinicians, researchers and partners are welcome to contact us to discuss Auracells™, our process and our data.
Ready to Learn About Auracells™?
Talk with a Patient Experience Executive at +1 844-888-6717 or info@auragens.com.
Contact Us